Sudarshan Pharma Industries Limited (SUDARSHAN) fundamentals
Sudarshan Pharma Industries Limited is a listed company, part of the Pharmaceuticals sector, listed on the NSE as SUDARSHAN (ISIN INE00TV01023). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Sudarshan Pharma Industries Limited does
Sudarshan Pharma Industries Limited is an India-based company, which is engaged in manufacturing, having a plant for API and doing jobwork manufacturing in Pharmaceutical Items and traders in Chemicals and Solvents in India. The Company is involved in specialty chemicals and intermediates for pharma, agricultural chemicals, coating, paints, adhesive, and various other industries. It is also focused on active pharmaceutical ingredient manufacturing. It is also into specialty chemicals imports and exports, as well as supplying the same to the actual users. The Company provides customized specialty chemicals to its clients in India and abroad regularly. The Company is involved in contract manufacturing, outsourcing and supplying generic pharma formulations and medicines to healthcare institutions, governments, non-governmental organizations (NGO) and hospitals. The Company operates in the states of Maharashtra, Gujarat and Uttarakhand.
Valuation and market data
| Last close | ₹36.42 |
|---|---|
| Market capitalisation | ₹877 crore |
| Enterprise value | ₹906 crore |
| P/E (TTM) | 37.55 |
| Price to book | 5.61 |
| Price to sales (TTM) | 0.72 |
| Book value per share | ₹6.49 |
| Dividend yield | 0.00% |
| Sector | Pharmaceuticals |
| Industry | — |
| Listed since | Tue Oct 27 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹676 crore | ₹29 crore | ₹22 crore | 0.91 |
| Mar 2025 | ₹505 crore | ₹19 crore | ₹14 crore | 0.58 |
| Mar 2024 | ₹468 crore | ₹15 crore | ₹11 crore | 0.47 |
| Mar 2023 | ₹462 crore | ₹10 crore | ₹7 crore | 5.48 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 57.8% |
|---|---|
| Foreign institutions (FII) | 21.9% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 20.2% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.